Niall Timothy Mulvihill, MD, MSc, FRCPI
Dr. Mulvihill is an honours graduate of the UCD School of Medicine. Initially his post graduate training was at the Mater Hospital and subsequently St. James’s Hospital, Dublin. He attained the following post graduate qualifications: (1) Membership of the Royal College of Physicians MRCPI (2) Masters in Cardiology MSc (University of Dublin) and (3) Doctorate in Medicine MD (University of Dublin).
Dr. Mulvihill spent two years as a Specialist Registrar at the Freeman Hospital, Newcastle upon Tyne, UK. He then travelled to the Clinique Pasteur, Toulouse, France to undertake a fellowship in Interventional Cardiology. Returning to Ireland in 2003 to St. James’s Hospital and Trinity College Dublin as Lecturer in Cardiology and Consultant Cardiologist. In 2014 he moved to St. Vincent’s Hosptial, Dublin where he works as a Consultant Cardiologist. Dr. Mulvihill also practices at St. Vincent’s Private Hospital and the Beacon Hospital, Dublin.
Dr. Mulvihill is an Interventional Cardiologist specialising in complex percutaneous coronary interventions. He trained in transradial techniques in Toulouse and was the first Cardiologist to perform angiography and coronary interventions via the radial artery in Ireland in 2003.
In his role as Consultant Cardiologist at St. Vincents he is a lecturer, tutor and examiner for undergraduate and post-graduate medical students at UCD School of Medicine. He continues to be an active educator and researcher in clinical and Interventional Cardiology. He is an active clinical trialist in international multicenter clinical trials in interventional cardiology focusing on drug eluting stents (ARTS, ARTS 2, CARDIA) and interventional techniques (BBC ONE; CELTIC). He is regularly invited to lecture nationally and internationally. Annually he is an invited faculty member for the following International Coronary Interventional meetings (EuroPCR; TCT; BCIS). Dr. Mulvihill was a co-founder and director of Ireland’s first live case Interventional Cardiology meeting at St. James’s Hospital. He is an invited operator for several International live case Interventional Cardiology meetings.
Dr Mulvihill works with many medical device companies as a research and clinical consultant. He performed the first-in-man clinical trial for the Celt ACDTM with Vasorum Ltd. This device has since received CE marking and FDA approval. He worked as a senior clinical advisor for Clearstream Technologies. He is an active member of several advisory boards for Pharmaceutical and Medical Technology companies.